•  
  •  
  •  
  •  

2025-10-02 07:09:18

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  MaxVenturesandIndustries

Stock Report

  • Max Estates' first luxury residential project in NCR garners pre-formal launch sales of INR 1,800+ crores
  • Max Estates receives NCLT Order for Delhi One
  • Max Estates enters Gurugram Residential Real Estate market with development potential of ~2.4 mn. sq. ft.
  • Max Ventures and Industries Ltd Q3 FY2023 consolidated net profit at Rs. 4.01 crore
  • Max Ventures and Industries Ltd posts consolidated PAT of Rs. 3.42 crores in Q2FY23
  • Max Estates completes acquisition of stake in Acreage Builders Pvt Ltd
  • Max Estates enters into Gurugram with 1.6 Mn sq.ft. commercial development opportunity
  • Max Estates Ltd forms new subsidiary
  • Max Estates receives confirmation from Axis Bank as the successful bidder for land parcels in Sector 129, Noida
  • Max Ventures and Industries Ltd posts Rs. 6.28 crores consolidated profit in Q1FY23
  • Max Estates Ltd completes acquisition of 100% in Accord Hotels and Resorts Pvt Ltd
  • Max Estates acquires ~10 acres of mixed use residential land parcel in Noida
  • Max Estates Ltd to acquire 100%in Accord Hotels and Resorts Pvt Ltd
  • Max Ventures and Industries Q4FY22 consolidated profit zooms to Rs. 319.34 crores
  • Max House Phase 1 in Okhla 100% leased out to marquee corporates
  • MaxVIL completes closing of 1st tranche of the divestment of balance 51% stake in its packaging business
  • Max Ventures and Industries Ltd Q3FY22 consolidated PAT jumps to Rs. 32.68 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024